Nottingham medical firm secures £1.4m

This post first appeared on East Midlands Business Link. Read the original article.

Nottingham medical firm secures £1.4m

A Midlands regenerative medicine company has secured a £1.4m investment to fund clinical trials on its new cutting-edge treatment for dry eye disease. The funding for NuVision Biotherapies Ltd comes in part from the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia and part of the Midlands Engine Investment Fund; […]